Holen Sie sich die Stockscreener-App
6.37
14.16%
0.79
Handel nachbörslich:
6.30
-0.07
-1.10%
Schlusskurs vom Vortag:
$5.58
Offen:
$5.45
24-Stunden-Volumen:
3.92M
Relative Volume:
3.55
Marktkapitalisierung:
$419.49M
Einnahmen:
$297.18M
Nettoeinkommen (Verlust:
$-51.64M
KGV:
-7.9298
EPS:
-0.8033
Netto-Cashflow:
$-50.72M
1W Leistung:
+20.87%
1M Leistung:
+58.06%
6M Leistung:
-6.46%
1J Leistung:
-46.96%
1-Tages-Spanne:
$5.45
$6.665
1-Wochen-Bereich:
$5.115
$6.665
52-Wochen-Spanne:
$3.86
$12.15
Evolus Inc Stock (EOLS) Company Profile
Firmenname
Evolus Inc
Sektor
Telefon
(949) 284-4555
Adresse
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Compare EOLS vs TAK, ZTS, TEVA, HLN, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EOLS
Evolus Inc
|
6.37 | 367.47M | 297.18M | -51.64M | -50.72M | -0.8033 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Evolus Inc Stock (EOLS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Herabstufung | Needham | Buy → Hold |
| 2025-04-17 | Eingeleitet | BTIG Research | Buy |
| 2024-01-29 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-06-23 | Eingeleitet | Needham | Buy |
| 2022-05-12 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-20 | Hochstufung | Truist | Hold → Buy |
| 2021-05-06 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-04-08 | Bestätigt | H.C. Wainwright | Buy |
| 2021-02-24 | Herabstufung | Truist | Buy → Hold |
| 2020-07-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2020-02-06 | Fortgesetzt | Mizuho | Buy |
| 2019-11-26 | Eingeleitet | SVB Leerink | Outperform |
| 2019-09-05 | Fortgesetzt | Mizuho | Buy |
| 2019-06-28 | Eingeleitet | Wells Fargo | Market Perform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-02-14 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-01-29 | Eingeleitet | Stifel | Buy |
Alle ansehen
Evolus Inc Aktie (EOLS) Neueste Nachrichten
Evolus, Inc. (NASDAQ:EOLS) Q1 2026 Earnings Call Transcript - Insider Monkey
Evolus, Inc. 2026 Q1 Financial Report: Key Risks, Financials, and Business Updates - Minichart
Evolus reiterates 2026 net revenue of $327M-$337M while targeting a low to mid-single-digit adjusted EBITDA margin - MSN
Earnings call transcript: Evolus misses Q1 2026 EPS forecast, revenue up - Investing.com UK
Evolus Q1 2026 earnings preview - MSN
Evolus, Inc. (EOLS) reports Q1 loss, tops revenue estimates - MSN
Evolus Sees 2026 Rev $327M-$337M >EOLS - Moomoo
Evolus Earnings Call Highlights Profitable Growth Path - TipRanks
Evolus, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance Singapore
Evolus Inc (NASDAQ:EOLS) Q1 2026 Earnings: Narrowed Loss and Positive EBITDA Drive After-Hours Rally - ChartMill
Evolus Q1 Earnings Call Highlights - Yahoo Finance
Evolus Posts Mixed Q1 Results - Orange County Business Journal
Evolus (EOLS) Q1 2026 Earnings Transcript - AOL.com
EOLS Reports Strong Q1 Revenue and Positive Adjusted EBITDA - GuruFocus
Evolus, Inc. 1Q 2026: Revenue $73.14M, EPS ($0.16) — 10-Q Summary - TradingView
Evolus (NASDAQ: EOLS) grows Q1 2026 sales but remains unprofitable - Stock Titan
Evolus Ends ATM Facility After Strong Q1 Momentum - TipRanks
Evolus Inc. (EOLS) stock falls on Q1 2026 Earnings - Quiver Quantitative
Evolus (NASDAQ: EOLS) Q1 2026 earnings, guidance and growth outlook - Stock Titan
Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook - Business Wire
Weight-loss revolution sparks new appetite for aesthetics firms - marketscreener.com
Trading the Move, Not the Narrative: (EOLS) Edition - Stock Traders Daily
Evolus (NASDAQ: EOLS) plans 2026 virtual meeting on directors, auditor and executive pay - Stock Titan
[ARS] Evolus, Inc. SEC Filing - Stock Titan
Evolus Deadline Alert - TMX Newsfile
Evolus Q1 2025 Earnings Preview - MSN
Evolus boosts balance sheet with lower-cost refinancing and flexibility - MSN
How The Evolus (EOLS) Story Is Shifting As Analysts Reset Growth And Valuation Assumptions - Yahoo Finance
EVOLUS DEADLINE ALERT - TMX Newsfile
Evolus, Inc. (NASDAQ:EOLS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Short Interest in Evolus, Inc. (NASDAQ:EOLS) Drops By 14.4% - MarketBeat
Evolus, Inc. (EOLS) Stock Analysis: Unpacking A 223% Potential Upside - DirectorsTalk Interviews
Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $15 - 富途牛牛
Evolus Targets Double-Digit Growth, Full-Year Profitability at Needham Healthcare Conference - Yahoo Finance
Evolus, Inc. (NASDAQ:EOLS) Q4 2025 earnings call transcript - MSN
Evolus to Report First Quarter Financial Results on May 4, 2026 - Barchart
Aug Big Picture: What analysts say about Evolus Inc stockQuarterly Investment Review & AI Based Trade Execution Alerts - baoquankhu1.vn
Bank Watch: What is the earnings history of Evolus Inc2026 Reactions & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
How safe is Evolus (EOLS) Stock dividend | Price at $4.25, Down 0.59%MA Crossover - Cổng thông tin điện tử Tỉnh Sơn La
Evolus and Oramed Pharmaceuticals Compared - National Today
How The Evolus (EOLS) Investment Story Is Shifting After Softer Guidance And Target Cuts - Yahoo Finance
Evolus (LTS:0K16) PB Ratio : (As of Apr. 10, 2026) - GuruFocus
Street Watch: Is Evolus Inc showing insider buying2026 PostEarnings & Real-Time Buy Signal Notifications - baoquankhu1.vn
EOLS Stock Price, Quote & Chart | EVOLUS INC (NASDAQ:EOLS) - ChartMill
Is Evolus (EOLS) Stock trading above fair value | Price at $4.12, Up 0.61%Expert Insights - Cổng thông tin điện tử Tỉnh Sơn La
Tech Rally: Is Evolus Inc undervalued by DCF analysisQuarterly Earnings Report & Verified Swing Trading Watchlists - baoquankhu1.vn
Winners Losers: Is Evolus Inc showing insider buying2026 EndofMonth & Breakout Confirmation Trade Signals - baoquankhu1.vn
EOLS Stock Analysis: Evolus Inc. Drops 6.5 Pct to 4.03 USD Near Term Support In Focus - Cổng thông tin điện tử tỉnh Tây Ninh
FY2026 Earnings Forecast for Evolus Issued By HC Wainwright - MarketBeat
Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference - BioSpace
Finanzdaten der Evolus Inc-Aktie (EOLS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.67%
2.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):